» Articles » PMID: 30407295

Breathlessness in Amyotrophic Lateral Sclerosis: A Case Report on the Role of Osteoporosis in the Worsening of Respiratory Failure

Overview
Specialty General Medicine
Date 2018 Nov 9
PMID 30407295
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative multisystem disorder, presenting with limb or bulbar onset. To date, there is no cure for ALS. At some stage of the disease, patients may complain of breathlessness due to respiratory failure, thus needing a noninvasive mechanical ventilation (NIMV) support. However, breathlessness is a symptom that may be induced by different causes that must be taken into consideration in ALS management.

Patients Concerns: We report the case of an 81-year-old man, with a spinal onset ALS, who was admitted to our clinic to start NIMV because of respiratory involvement. After 3 weeks from NIMV performed at night time, with beneficial effects, he suddenly complained of breathlessness even at rest and in standing position.

Diagnosis: Respiratory and cardiac assessments did not show new clinical events, indicating the worsening respiratory function. Due to a history of osteoporosis which was treated with biphosphonates and even though no previous bone trauma or falls were reported, we performed a spine computed tomography scan. The findings indicated multiple dorsal vertebral fractures which was a probable cause for breathlessness.

Interventions And Outcomes: Considering the neurodegenerative disease associated to respiratory failure, the cardiovascular risk factors and the age, the patient refused to undergo a surgery with kyphoplasty. A spine support was then prescribed, together with analgesic medications, with significant alleviation of pain and breathlessness.

Lessons: The occurrence of breathlessness in a patient with ALS cannot always be related to the bulbar involvement. Other causes should be taken into account, especially when there is sudden worsening of symptoms in spite of good clinical response and compliance to NIMV treatment.

Citing Articles

Amyotrophic lateral sclerosis and osteoporosis: a two-sample Mendelian randomization study.

Li J, Ma C, Huang H, Liao H Front Aging Neurosci. 2024; 15:1305040.

PMID: 38161591 PMC: 10757610. DOI: 10.3389/fnagi.2023.1305040.


A novel protocol to derive cervical motor neurons from induced pluripotent stem cells for amyotrophic lateral sclerosis.

Yang M, Liu M, Sanchez Y, Avazzadeh S, Quinlan L, Liu G Stem Cell Reports. 2023; 18(9):1870-1883.

PMID: 37595581 PMC: 10545486. DOI: 10.1016/j.stemcr.2023.07.004.


Effects of Neurological Disorders on Bone Health.

Kelly R, Sidles S, LaRue A Front Psychol. 2021; 11:612366.

PMID: 33424724 PMC: 7793932. DOI: 10.3389/fpsyg.2020.612366.

References
1.
Lyall R, Donaldson N, Polkey M, Leigh P, Moxham J . Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001; 124(Pt 10):2000-13. DOI: 10.1093/brain/124.10.2000. View

2.
Aaseth J, Boivin G, Andersen O . Osteoporosis and trace elements--an overview. J Trace Elem Med Biol. 2012; 26(2-3):149-52. DOI: 10.1016/j.jtemb.2012.03.017. View

3.
Calvo A, Manzano R, Mendonca D, Munoz M, Zaragoza P, Osta R . Amyotrophic lateral sclerosis: a focus on disease progression. Biomed Res Int. 2014; 2014:925101. PMC: 4137497. DOI: 10.1155/2014/925101. View

4.
Kanis J . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994; 4(6):368-81. DOI: 10.1007/BF01622200. View

5.
Chen X, Wang K, Wang Z, Gan C, He P, Liang Y . Effects of lead and cadmium co-exposure on bone mineral density in a Chinese population. Bone. 2014; 63:76-80. DOI: 10.1016/j.bone.2014.02.017. View